Emergence of Exhausted B Cells in Asymptomatic HIV-1-Infected Patients Naïve for HAART is Related to Reduced Immune Surveillance

Table 1

Profiles of asymptomatic HIV-1-infected patients.

Patients	Sex	Age (years)	HIV-1 risk group	CDC stage	HIV-1 viral load (RNA copies/mL)	CD4 T cell count (cell/μL)
1	M	49	Heterosex	A1	6342	500
2	F	33	Heterosex	A2	760	471
3	M	30	Heterosex	A1	<50*	650
4	F	40	Heterosex	A1	9893	470
5	F	21	Heterosex	A1	160116	786
6	F	72	Heterosex	A1	2940	536
7	M	55	Homosex/bisex	A1	76871	477
8	M	27	Heterosex	A1	39880	540
9	F	44	Heterosex	A1	9337	487
10	F	42	Heterosex	A1	74	857
11	F	48	Heterosex	B1	62078	505
12	M	48	Unknown	A1	6778	384
13	M	28	Unknown	A1	58322	622
14	M	26	Homosex/bisex	A1	274979	550
15	F	36	Drugs user	B1	1332	454
16	M	43	Homosex/bisex	A2	27684	356
17	F	43	Heterosex	A1	1201	417
18	M	30	Drugs user	A1	15756	523
19	M	33	Heterosex	A1	789	742
20	M	42	Hematic product contact	A1	107	570
21	M	47	Drugs user	A1	323	552
22	M	47	Drugs user	A1	<50	684
23	M	50	Heterosex	A1	55681	510
24	M	55	Heterosex	A2	67431	481
25	M	45	Heterosex	A1	14781	386
26	F	46	Heterosex	A1	143	494
27	F	54	Heterosex	A1	276	417
28	M	32	Homosex/bisex	A1	11091	685
29	M	28	Heterosex	A1	362	620
30	M	34	Heterosex	A1	16841	668
31	F	48	Drugs user	A1	<50	640
32	M	44	Drugs user	A1	<50	2049
33	F	24	Drugs user	A2	49716	469
34	M	49	Homosex/bisex	A2	3569	489
35	F	28	Heterosex	A1	6390	555
36	M	49	Heterosex	A1	487	834
37	M	39	Heterosex	A1	32750	523
38	M	35	Homosex/bisex	A2	1121	408
39	M	49	Homosex/bisex	A1	13057	496
40	M	39	Homosex/bisex	A2	40811	478
41	M	40	Homosex/bisex	A2	1713	474
42	M	43	Homosex/bisex	A2	29763	355
43	M	43	Homosex/bisex	A1	62035	574

*<50 HIV-1 RNA copies/mL: undetectable levels.